Guru Ownership Trend
Guru Analysis for Cytokinetics, Incorporated (CYTK)
Cytokinetics, Incorporated (CYTK), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $130.81 M.
Top institutional holders include Ken Fisher and Steven Cohen.
Institutional sentiment is currently Bullish. This is evidenced by a $20.11 M net inflow during the quarter.
Recent activity highlights Steven Cohen who opened a new position. Conversely, Cliff Asness reduced exposure by 33.9%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Cytokinetics, Incorporated (CYTK)
Major holders include Ken Fisher ($50.64 M), Steven Cohen ($41.27 M), Cliff Asness ($10.32 M). According to the latest reported data, 5 tracked investment managers collectively hold approximately 1.7 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $20.11 M, with 1 managers increasing positions and 4 managers reducing holdings.
During the most recent reporting period, 3 managers trimmed their positions, while 1 fully exited CYTK. The total reported sell value was $21.16 M.
Yes, 1 managers opened new positions in CYTK, and 0 increased their existing holdings. The total reported buy value was $41.27 M.